|
|
Article: As I see it: FDA targets Lopressor, Tenormin. (Food and Drug Administration's regulations on drug promotion)
- Article from:
- Medical Marketing & Media
- Article date:
- January 1, 1992
- Author:
CopyrightCOPYRIGHT 1992 Haymarket Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Like all good military commanders, when FDA Commissioner David A. Kessler parleys with the enemy, he brings his sword to the table. And so it was in November, when FDA-industry dialog opened on new drug promotion/continuing medical education guidelines, Kessler's agency sent two warning letters to ICIC Pharmaceuticals Group (over Tenormin print ads) and CIBA-GEIGY Corp. (over Lopressor print ads.).
The military analogy is not overdrawn. Even if Kessler does not see FDA's relationship as a war with the pharmaceutical marketing community, he -- and thus the people lower down in the Division of Drug Marketing, Advertising and Communications -- nonetheless views it ...